Business Standard

Ipca Laboratories acquires further 20% stake in Bayshore, New Jersey

Image

Capital Market

For consideration of USD 1.2 mn

Ipca Laboratories announced that its wholly owned subsidiary, Ipca Laboratories Inc. USA has acquired another 20% share capital of Bayshore Pharmaceuticals (Bayshore), a New Jersey limited liability company for cash consideration of USD 1.2 million. With this acquisition, Bayshore is now a wholly owned step-down subsidiary of the company.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 01 2021 | 1:19 PM IST

Explore News